| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,580,354 | 3,625,017 | 2,914,268 | 3,678,394 | | Cost of Revenue | 2,315,175 | 2,417,680 | 1,983,400 | 2,412,454 | | | Gross Profit | 1,265,179 | 1,207,337 | 930,868 | 1,265,940 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 720,042 | 786,823 | 732,739 | 800,213 | | Non Recurring | 12,000 |
-
| 89,997 |
-
| | Others | 49,542 | 51,947 | 50,570 | 51,614 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 483,595 | 368,567 | 57,562 | 414,113 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,139 | (20,488) | (3,692) | (14,457) | | Earnings Before Interest And Taxes | 494,734 | 348,079 | 53,870 | 399,656 | | Interest Expense | 45,670 | 44,024 | 31,298 | 40,346 | | Income Before Tax | 449,064 | 304,055 | 22,572 | 359,310 | | Income Tax Expense | 146,100 | 103,700 | 52,000 | 86,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 302,964 | 200,355 | (29,428) | 273,310 | | | Non-recurring Events | | Discontinued Operations | (546) | (23,790) | (9,946) | (39,536) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 302,418 | 176,565 | (39,374) | 233,774 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $302,418 | $176,565 | ($39,374) | $233,774 |
|
0.29% Nasdaq 
0.03 (0.06%) 
Income Statement
